Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus)

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Carlson, Linda E ^a,b,c   Bultz, Barry D ^a,b,c   Morris, Donald G ^b,c  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Advanced cancer; Depression; Phase I trials; Quality of life; Spirituality

Indexed keywords

ANTINEOPLASTIC AGENT; REOLYSIN; UNCLASSIFIED DRUG; RAS PROTEIN;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BONE METASTASIS; BRAIN METASTASIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER; CANCER MORTALITY; CANCER REGRESSION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE DISEASE; FAMILY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERVIEW; KLATSKIN TUMOR; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; MENTAL STRESS; NECK METASTASIS; PANCREAS ISLET CELL TUMOR; PHASE 1 CLINICAL TRIAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RETROPERITONEAL CANCER; SCORING SYSTEM; SKIN METASTASIS; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; DEPRESSION; DRUG EFFECT; HUMAN EXPERIMENT; IMMUNOLOGY; MAMMALIAN ORTHOREOVIRUS; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RELIGION; RETROVIRUS; SICKNESS IMPACT PROFILE; VIROLOGY;

ADULT; AGED; CLINICAL TRIALS, PHASE I AS TOPIC; DEPRESSION; FEMALE; HUMANS; MALE; MAMMALIAN ORTHOREOVIRUS 3; MIDDLE AGED; NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RAS PROTEINS; RETROVIRIDAE; SICKNESS IMPACT PROFILE; SPIRITUALITY; STRESS, PSYCHOLOGICAL; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 16344383827     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-3-7     Document Type: Article

References (36)

1. Feld R: Endpoints in cancer clinical trials: Is there a need for measuring quality of life? Supportive Care in Cancer 1995, 3:23-27.
2. Morris J, Perez D, McNoe B: The use of quality of life data in clinical practice. Quality of Life Research 1998, 7: 5-91.
3. Kiebert GM, Curran D, Aaronson NK: Quality of life as an endpoint in EORTC clinical trials. Statistics in Medicine 1998, 17:561-569.
4. Spilker B: Quality of Life Assessments in Clinical Trials Edited by: Spilker B. New York, Raven Press; 1990.
5. Taylor K, Macdonald K, Bezjak A, Ng P, Depetrillo AD: Physicians' perspective on quality of life: an exploratory study of oncologists. Quality of Life Research 1996, 5:5-14.
6. Gough I, Dalgleish L: What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer? Cancer 1991, 68: 20-225.
7. Schwarz R, Bernhard J, Flechtner H, Hurny C, Kuchler T: Guidelines for the assessment of quality of life in oncology - implementing adequate methods and their content. Journal of Cancer Research and Clinical Oncology 1994, 120:691-692.
8. Melink TJ, Clark GM, Von Hoff DD: The impact of phase I clinical trials on the quality of life of patients with cancer. Anticancer Drugs 1992, 3:571-576.
9. Hutchison C: Phase I trials in cancer patients: participants' perceptions. Eur J Cancer Care (Engl) 1998, 7: 5-22.
10. Cheng JD, Hitt J, Koczwara B, Schulman KA, Burnett CB, Gaskin DJ, Rowland JH, Meropol NJ: Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 2000, 18:421-428.
11. Coffey MC, Strong JE, Forsyth PA, Lee PW: Reovirus therapy of tumors with activated Ras pathway. Science 1998, 282: 332-1334.
12. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, DiFrancesco LM, Strong JE, Lee PW: Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002, 13:641-652.
13. Wilcox ME, Yang W, Senger D, Rewcastle NB, Morris DG, Brasher PM, Shi ZQ, Johnston RN, Nishikawa S, Lee PW, Forsyth PA: Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst 2001, 93:903-912.
14. O'Boyle CA, Browne J, Hickey A, McGee HM, & Joyce CRB: Schedule for the Evaluation of Individual Quality of Life (SEIQoL): A Direct Weighting Procedure for Quality of Life Domains (SEIQoL-DW). Administration Manual. Dublin, Ireland, Department of Psychology, Royal College of Surgeons; 1995.
15. O'Boyle CA, McGee HM, Hickey A, Joyce CRB, Browne J, O'Malley K, Hiltbrunner B: The schedule for the evaluation of individual quality of life (SEIQoL): Administration manual Dublin, Royal College of Surgeons in Ireland; 1993.
16. Broadhead JK, Robinson JW, Atkinson MJ: A new quality of life measure for oncology: The SEIQoL. Journal of Psychosocial Oncology 1998, 16:21-35.
17. Waldron D, O'Boyle CA, Kearney M, Moriarty M, Carney D: Quality of life measurement in advanced cancer: Assessing the individual. Journal of Clinical Oncology 1999, 17:3603-3611.
18. Campbell S, Whyte F: The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW. Journal of Advanced Nursing 1999, 30:335-343.
19. Smith HJ, Taylor R, Mitchell A: A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart 2000, 84:390-394.
20. Highfield MF: Spiritual health of oncology patients. Cancer Nursing 1992, 15:1-8.
21. Derogatis LR, Melisaratos N: The brief symptom inventory: An introductory report. Psychological Medicine 1983, 13: 95-605.
22. Beck AT, Ward CH, Mendelson M: An inventory for measuring depression. Archives of General Psychiatry 1961, 4: 61-571.
23. Berdel WE, Knopf H, Fromm M, Schick HD, Busch R, Fink U, Sellschopp A, Rastetter J: Influence of phase I early clinical trials on the quality of life of cancer patients. A pilot study. Anticancer Res 1988, 8:313-321.
24. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W: A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 1996, 313:29-33.
25. Aaronson NK, Ahmedzai S, Bullinger M, Crabeels D, Estape J, Filiberti A, Flechtner H, Frick U, Hurny C, Kaasa S, Klee M, Mastilica M, Osoba D, Pfausler B, Razavi D, Rofe PB, Schraub S, Sullivan M, Takeda F: The EORTC core quality of life questionnaire: Interim results of an international field study. In Effect of Cancer on Quality of Life Edited by: Osoba D. London, CRC Press; 1991:185-203.
26. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, deHaes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993, 85: 65-376.
27. Bayle B, Kemoun G, Migaud H, Thevenon A: Comparison of two modes of administration of a personalized quality of life scale in a longitudinal study of total hip arthroplasty. Joint Bone Spine 2000, 67:101-106.
28. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CR: Individual quality of life in patients undergoing hip replacement. Lancet 1992, 339:1088-1091.
29. Lintern TC, Beaumont JG, Kenealy PM, Murrell RC: Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Qual Life Res 2001, 10:371-378.
30. Bromberg MB, Forshew DA: Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002, 58:320-322.
31. Michelson H, Bolund C, Nilsson B, Brandberg Y: Health-related quality of life measured by the EORTC QLQ-C30 - reference values from a large sample of Swedish population. Acta Oncol 2000, 39:477-484.
32. Coates A, Porzsolt F, Osoba D: Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997, 33:1025-1030.
33. Buccheri G: Depressive reactions to lung cancer are common and often followed by a poor outcome. European Respiratory Journal 1998, 11:173-178.
34. Herndon JE, Fleishman SB, Kornblith AB, Kosty M, Green MR, Holland J: Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999, 85: 33-340.
35. Zabora JR, Blanchard CG, Smith ED, Roberts CS, Glajchen M, Sharp JW, BrintzenhofeSzoc KM, Locher JW, Carr EW, Best-Castner S, Smith PM, Dozier-Hall D, Polinsky ML, Hedlund SC: Prevalence of psychological distress among cancer patients across the disease continuum. Journal of Psychosocial Oncology 1997, 15: 3-87.
36. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S: The prevalence of psychological distress by cancer site. Psychooncology 2001, 10:19-28.